BioTech News at Arizona Biotech
Biotech News <<< Mailing List
Biotechnology News <<< Discussion Forums
Thursday, September 15, 2005
Biotech Stocks: Biopharma indexes diverge, Dendreon soars - Biotechnology - Pharmaceuticals - Stock Reports - Market News
Biotech Stocks: Biopharma indexes diverge, Dendreon soars - Biotechnology - Pharmaceuticals - Stock Reports - Market News
BIOTECH STOCKS
Biopharma indexes diverge, Dendreon soars
By Val Brickates Kennedy, MarketWatch
BOSTON (MarketWatch)-The benchmark sector indexes diverged on Wednesday while shares of Dendreon staged a late-day rally on positive news for its drug Provenge.
The Amex Biotechnology Index
Dendreon (DNDN: news, chart, profile) shot up 13%
Celgene (CELG: news, chart, profile) shares rose 4% to $54.77, after being halted
An advisory panel of the Food and Drug Administration voted midday to recommend Revlimid be approved to treat a type of anemia caused by myelodysplastic syndromes, a group of diseases that cripple the body's ability to make healthy blood cells.
Progenics Pharmaceuticals

